S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.05 (+0.92%)
AAPL   177.81 (-1.63%)
MSFT   412.43 (-0.29%)
META   499.53 (+1.92%)
GOOGL   137.76 (-0.51%)
AMZN   177.79 (+0.58%)
TSLA   200.84 (-0.52%)
NVDA   819.14 (+3.54%)
NIO   5.81 (+1.04%)
AMD   199.76 (+3.76%)
BABA   74.86 (+1.12%)
T   16.96 (+0.18%)
F   12.49 (+0.40%)
MU   95.47 (+5.36%)
CGC   3.28 (-0.30%)
GE   159.11 (+1.42%)
DIS   111.46 (-0.11%)
AMC   4.41 (+2.08%)
PFE   26.63 (+0.26%)
PYPL   60.45 (+0.18%)
XOM   106.31 (+1.71%)
S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.05 (+0.92%)
AAPL   177.81 (-1.63%)
MSFT   412.43 (-0.29%)
META   499.53 (+1.92%)
GOOGL   137.76 (-0.51%)
AMZN   177.79 (+0.58%)
TSLA   200.84 (-0.52%)
NVDA   819.14 (+3.54%)
NIO   5.81 (+1.04%)
AMD   199.76 (+3.76%)
BABA   74.86 (+1.12%)
T   16.96 (+0.18%)
F   12.49 (+0.40%)
MU   95.47 (+5.36%)
CGC   3.28 (-0.30%)
GE   159.11 (+1.42%)
DIS   111.46 (-0.11%)
AMC   4.41 (+2.08%)
PFE   26.63 (+0.26%)
PYPL   60.45 (+0.18%)
XOM   106.31 (+1.71%)
S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.05 (+0.92%)
AAPL   177.81 (-1.63%)
MSFT   412.43 (-0.29%)
META   499.53 (+1.92%)
GOOGL   137.76 (-0.51%)
AMZN   177.79 (+0.58%)
TSLA   200.84 (-0.52%)
NVDA   819.14 (+3.54%)
NIO   5.81 (+1.04%)
AMD   199.76 (+3.76%)
BABA   74.86 (+1.12%)
T   16.96 (+0.18%)
F   12.49 (+0.40%)
MU   95.47 (+5.36%)
CGC   3.28 (-0.30%)
GE   159.11 (+1.42%)
DIS   111.46 (-0.11%)
AMC   4.41 (+2.08%)
PFE   26.63 (+0.26%)
PYPL   60.45 (+0.18%)
XOM   106.31 (+1.71%)
S&P 500   5,117.99 (+0.43%)
DOW   39,026.39 (+0.08%)
QQQ   443.05 (+0.92%)
AAPL   177.81 (-1.63%)
MSFT   412.43 (-0.29%)
META   499.53 (+1.92%)
GOOGL   137.76 (-0.51%)
AMZN   177.79 (+0.58%)
TSLA   200.84 (-0.52%)
NVDA   819.14 (+3.54%)
NIO   5.81 (+1.04%)
AMD   199.76 (+3.76%)
BABA   74.86 (+1.12%)
T   16.96 (+0.18%)
F   12.49 (+0.40%)
MU   95.47 (+5.36%)
CGC   3.28 (-0.30%)
GE   159.11 (+1.42%)
DIS   111.46 (-0.11%)
AMC   4.41 (+2.08%)
PFE   26.63 (+0.26%)
PYPL   60.45 (+0.18%)
XOM   106.31 (+1.71%)

TrueBlue (TBI) Stock Price, News & Analysis

$11.89
+0.14 (+1.19%)
(As of 11:44 AM ET)
Today's Range
$11.60
$11.95
50-Day Range
$11.04
$15.64
52-Week Range
$10.15
$19.10
Volume
73,891 shs
Average Volume
259,536 shs
Market Capitalization
$373.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00

TrueBlue MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
59.8% Upside
$19.00 Price Target
Short Interest
Bearish
5.28% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.52mentions of TrueBlue in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.51) to $1.11 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.56 out of 5 stars

Business Services Sector

176th out of 315 stocks

Help Supply Services Industry

14th out of 16 stocks


TBI stock logo

About TrueBlue Stock (NYSE:TBI)

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company's PeopleReady segment provides general, industrial, and skilled trade staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. Its PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company's PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform which uses artificial intelligence and machine learning for real-time insights; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington.

TBI Stock Price History

TBI Stock News Headlines

TrueBlue, Inc. (NYSE:TBI) Q4 2023 Earnings Call Transcript
Trueblue (TBI) Poised for Growth as Sector Recovers: Buy Rating Affirmed
Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Is TrueBlue, Inc. (NYSE:TBI) Trading At A 34% Discount?
Q4 2023 TrueBlue Inc Earnings Call
TrueBlue: Q4 Earnings Insights
TrueBlue: Q4 Earnings Snapshot
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
TrueBlue Reports Fourth Quarter and Full-Year 2023 Results
TrueBlue earnings preview: what Wall Street is expecting
TrueBlue Inc
Richard Pzena Increases Stake in TrueBlue Inc
TrueBlue Recognized for Women in Leadership
TrueBlue: A Suspect Rebound
See More Headlines
Receive TBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
3/01/2024
Next Earnings (Estimated)
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
5,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$20.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+61.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,170,000.00
Pretax Margin
-1.08%

Debt

Sales & Book Value

Annual Sales
$1.91 billion
Cash Flow
$1.40 per share
Book Value
$14.59 per share

Miscellaneous

Free Float
30,132,000
Market Cap
$368.83 million
Optionable
Optionable
Beta
1.52
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Ms. Taryn R. OwenMs. Taryn R. Owen (Age 45)
    CEO, President & Director
    Comp: $1.49M
  • Mr. Carl R. Schweihs (Age 39)
    Chief Financial Officer
    Comp: $1.1M
  • Mr. Garrett R. Ferencz (Age 46)
    Executive VP, General Counsel, Chief Ethics & Compliance Officer, Chief Legal Officer and Secretary
    Comp: $829.56k
  • Mr. Richard B. Christensen (Age 47)
    Senior VP, Chief Accounting Officer & Treasurer
  • Mr. Jeff Dirks
    Chief Technology & Information Officer
  • Ms. Caroline Sabetti
    Chief Marketing & Communications Officer
  • Mr. Greg Netolicky
    Chief People Officer
  • Mr. Anthony Brew
    Chief Diversity Officer
  • Mr. Richard P. Betori
    President of PeopleScout
  • Ms. Kristy Willis
    President of PeopleReady














TBI Stock Analysis - Frequently Asked Questions

Should I buy or sell TrueBlue stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TBI shares.
View TBI analyst ratings
or view top-rated stocks.

What is TrueBlue's stock price target for 2024?

1 Wall Street analysts have issued 1 year price objectives for TrueBlue's shares. Their TBI share price targets range from $18.00 to $20.00. On average, they expect the company's share price to reach $19.00 in the next year. This suggests a possible upside of 59.8% from the stock's current price.
View analysts price targets for TBI
or view top-rated stocks among Wall Street analysts.

How have TBI shares performed in 2024?

TrueBlue's stock was trading at $15.34 at the start of the year. Since then, TBI shares have decreased by 22.5% and is now trading at $11.89.
View the best growth stocks for 2024 here
.

Are investors shorting TrueBlue?

TrueBlue saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 1,520,000 shares, an increase of 8.6% from the January 15th total of 1,400,000 shares. Based on an average daily volume of 315,200 shares, the days-to-cover ratio is currently 4.8 days. Currently, 5.1% of the shares of the stock are sold short.
View TrueBlue's Short Interest
.

When is TrueBlue's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our TBI earnings forecast
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) released its quarterly earnings data on Wednesday, February, 21st. The business services provider reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.23. The business services provider earned $492.17 million during the quarter, compared to the consensus estimate of $472.53 million. TrueBlue had a negative net margin of 0.74% and a positive trailing twelve-month return on equity of 2.39%. The business's quarterly revenue was down 11.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 earnings per share.

What ETF holds TrueBlue's stock ?

First Trust Dow Jones Select Microcap Index Fund holds 83,212 shares of TBI stock, representing 0.79% of its portfolio.

What guidance has TrueBlue issued on next quarter's earnings?

TrueBlue updated its first quarter 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $392.0 million-$417.0 million, compared to the consensus revenue estimate of $425.3 million.

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pzena Investment Management LLC (9.93%), Vanguard Group Inc. (8.32%), Dimensional Fund Advisors LP (6.58%), Charles Schwab Investment Management Inc. (2.88%), Hotchkis & Wiley Capital Management LLC (2.60%) and Bridgeway Capital Management LLC (1.58%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Derrek Lane Gafford, Garrett Ferencz, Kim Harris Jones, Kristi A Savacool, Kristy A Fitzsimmons-Willis, Richard Christensen, Richard P Betori, Robert C Kreidler, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends
.

How do I buy shares of TrueBlue?

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:TBI) was last updated on 3/1/2024 by MarketBeat.com Staff